Observational studyMediators of inflammation2026
Admission Serum Ferritin Levels as a Predictor of Severe Disease in Hospitalized Pediatric Patients in Mexico.
Observational study in Mediators of inflammation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Admission Serum Ferritin Levels as a Predictor of Severe Disease in Hospitalized Pediatric Patients in Mexico.Mediators of inflammation · 2026Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionBiomarkers that predict the severity of a disease on admission would be a valuable tool for pediatricians. Ferritin has been proposed as a predictive biomarker for various conditions; however, multiple thresholds have been described depending on the diagnosis. A threshold for severe pediatric disease regardless of the final diagnosis is lacking. MATERIAL AND
methodsWe performed a single-center retrospective observational study of patients admitted to the emergency department (ED) of a pediatric reference hospital in Mexico. Serum ferritin levels were requested to all admitted patients <16 years old and included in the study. Risk prediction models for various clinical outcomes were built using receiver operating characteristic (ROC) curves.
resultsAdmission ferritin levels were significantly higher in patients who required vasopressors (p < 0.001), blood transfusion (p < 0.001), and admission to the pediatric intensive care unit (PICU; p < 0.001). Patients with admission ferritin >500 ng/mL had a longer hospital stay (p = 0.037). Admission ferritin was a predictor of all-cause mortality (area under the curve [AUC] = 0.67, 95% confidence interval [CI]: 0.54-0.80, p = 0.009; sensitivity 55%, specificity 76.3%). A cut-off point of 385 ng/mL was associated with mortality (OR 3.21, 95% CI: 1.29-7.97).
conclusionWe provide evidence that ferritin may be used as a predictive biomarker in the pediatric ED. In our study, ferritin levels on admission predicted all-cause mortality. Multicenter studies are required to validate our findings in a larger sample.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.